Power Law company profile

Adaptive Biotechnologies

Biotech & Life Sciences · Seattle, United States · Founded 2009 · IPO 2019 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$2.01B

Market cap · Apr/2026

Revenue

$277M

Latest reported FY

Investors

6 investors on Adaptive Biotechnologies's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 6 investors entered at this stage

Global footprint

AI talent share

1.2% of workforce is AI talent
(8 of 659 staff)

Core AI30.46%

Other AI50.76%

Non-AI workforce65198.79%

Web traffic by country

24K monthly visits
across markets

🇺🇸 United States77.1%

🇬🇧 United Kingdom7.1%

🇨🇦 Canada4.6%

🇮🇳 India3.3%

🇯🇵 Japan2.1%

Top 5 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo